Clinical trial
Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer
NCT00100945 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00100945 |
|---|---|
| Title | Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer |
| Official title | A Phase II Study Of Maintenance ZD1839 (IRESSA) In Patients With Locally Advanced Esophageal Cancer After Treatment Given With Curative Intent |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug |
| Interventions | gefitinib |
| Enrollment | 70 |
| Start date | Jul 1, 2005 |
| Primary completion | Aug 1, 2007 |
| Completion | Oct 1, 2009 |
| First posted | Jan 10, 2005 |
| Last update posted | Dec 13, 2016 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: